Khan, S.S.; Rangraze, I.R.; Wali, A.F.; Jhancy, M.; Attia, R.A.; Elshamly, H.A.H.; Adam, S.; Elbeshbeishy, R.A.M.
Repurposing Metformin in Precision Oncology: Mechanistic Insights, Biomarker-Guided Strategies, and Translational Imperatives. Medicina 2025, 61, 1577.
https://doi.org/10.3390/medicina61091577
AMA Style
Khan SS, Rangraze IR, Wali AF, Jhancy M, Attia RA, Elshamly HAH, Adam S, Elbeshbeishy RAM.
Repurposing Metformin in Precision Oncology: Mechanistic Insights, Biomarker-Guided Strategies, and Translational Imperatives. Medicina. 2025; 61(9):1577.
https://doi.org/10.3390/medicina61091577
Chicago/Turabian Style
Khan, Shehla Shafi, Imran Rashid Rangraze, Adil Farooq Wali, Malay Jhancy, Rasha Aziz Attia, Hesham Amin Hamdy Elshamly, Shukri Adam, and Rana Aly Mohamed Elbeshbeishy.
2025. "Repurposing Metformin in Precision Oncology: Mechanistic Insights, Biomarker-Guided Strategies, and Translational Imperatives" Medicina 61, no. 9: 1577.
https://doi.org/10.3390/medicina61091577
APA Style
Khan, S. S., Rangraze, I. R., Wali, A. F., Jhancy, M., Attia, R. A., Elshamly, H. A. H., Adam, S., & Elbeshbeishy, R. A. M.
(2025). Repurposing Metformin in Precision Oncology: Mechanistic Insights, Biomarker-Guided Strategies, and Translational Imperatives. Medicina, 61(9), 1577.
https://doi.org/10.3390/medicina61091577